Trials / Conditions / Non-erosive Reflux Disease

Non-erosive Reflux Disease

29 registered clinical trials studyying Non-erosive Reflux Disease — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Evaluation of the Efficacy and Safety of Eolo in Patients With NERD NCT07041060	University of Bologna	N/A
Unknown	Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Dis NCT06121830	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease NCT05890001	Braintree Laboratories	Phase 3
Completed	A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease NCT05587322	Braintree Laboratories	Phase 3
Unknown	Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D NCT05369884	Xiyuan Hospital of China Academy of Chinese Medical Sciences	EARLY_Phase 1
Unknown	Comorbid Esophageal Disorders in IBS Patients NCT04759378	Assiut University	N/A
Recruiting	Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adher NCT04255693	Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology	N/A
Unknown	Study of Dietary Patterns and Food Diversity in Russian GERD Patients NCT04252144	Russian Academy of Medical Sciences	N/A
Completed	Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients NCT03967886	Yooyoung Pharmaceutical Co., Ltd.	Phase 3
Completed	Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD NCT03444883	Il-Yang Pharm. Co., Ltd.	Phase 3
Completed	A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the E NCT03591653	Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.	Phase 3
Unknown	Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease NCT02892357	Xiyuan Hospital of China Academy of Chinese Medical Sciences	Phase 1 / Phase 2
Completed	Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease NCT02556021	HK inno.N Corporation	Phase 3
Completed	Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD NCT02575287	Instituto Ecuatoriano de Enfermedades Digestivas	—
Terminated	Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection NCT02788591	LCMC Health	N/A
Unknown	S-pantoprazole 10mg Phase III Clinical Study NCT02274961	Ahn-Gook Pharmaceuticals Co.,Ltd	Phase 3
Unknown	The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients NCT02149914	Taichung Tzu Chi Hospital	N/A
Completed	Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-er NCT01750437	Yuhan Corporation	Phase 2
Completed	Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-b NCT01269788	Tehran University of Medical Sciences	Phase 2 / Phase 3
Completed	Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients NCT01119768	AstraZeneca	Phase 4
Completed	Detection of Minimal Change Esophagitis by I-scan NCT01560910	arpa pungrasamee	—
Completed	Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study NCT02081404	Midwest Biomedical Research Foundation	N/A
Completed	Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders NCT00830115	Nycomed	—
Completed	Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients NCT01797939	Seoul National University Bundang Hospital	—
Completed	Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) NCT00562094	Nycomed	—
Terminated	The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (B NCT00449813	Takeda	Phase 4
Completed	A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux D NCT00259051	AstraZeneca	Phase 3
Completed	Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population NCT00259077	AstraZeneca	Phase 3
Withdrawn	Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD) NCT02039869	Virginia Commonwealth University	N/A